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S_may The authors report on 182 cases of intrathoracic metastases (ITM=lung, pleura or mediastinum)
observed as first single recurrences in the course of the follow-up of patients treated for primary breast
cancer. ITM were detected on standard two-views chest X-ray (CXR) at regular follow-up visits and in
absence of subjective symptoms (102 A cases) or in the interval between two consecutive planned controls
because of the onset of subjective symptoms (80 S cases). The average disease-free interval since primary
treatment was significantly shorter in A with respect to S cases (40.3 vs. 28.5 months, P<0.001) as a
consequence of the early detection achieved by CXR survey. On the contrary, prognosis was not influenced
by ITM early diagnosis as the 10-year survival since primary treatment did not differ significantly between A
or S cases (12% vs. 10%, P=0.68). Results were confirmed on multivariate (Cox's) analysis, adjusting for
potential confounders such as age or nodal status. Periodic CXR survey looks a very questionable policy as it
does not seem to have any favourable impact on prognosis. Its routine use in breast cancer patients should
thus be carefully reconsidered.
Periodic follow-up of breast cancer patients is a common
policy and specific programmes have been devised (Horton,
1984; Humphrey et al., 1982). Nevertheless, routine tests for
systemic disease have been criticised for being expensive and
because no convincing evidence has been produced thus far
of a favourable prognostic impact of early detection and
treatment of distant metastases (Andreoli et al., 1987; Ciatto
et al., 1985; Dewar & Kerr, 1985; Hughes & Courtney,
1985).
Standard two-views chest X-ray (CXR) is commonly
employed to detect intrathoracic metastases (ITM) to the
lung, pleura or mediastinum which represents a relatively
frequent pattern of first recurrence (Ciatto et al., 1985).
The aim of the present report was to review a large series
of patients undergoing periodic CXR survey and to assess
the diagnostic and prognostic impact of this procedure.
Patients and methods
The study evaluates 182 cases of isolated ITM observed out
of 1,225 first recurrences in a consecutive series of breast
cancer patients treated by radical mastectomy or quadrantec-
tomy, axillary dissection and breast irradiation from June
1971 to December 1982 and regularly followed up until
October 1987. Patients age ranged from 26 to 82 years
(average 53.4 years). ITM had been excluded at primary
treatment by CXR survey. CXR and physical examination
were repeated every 6 months in the first five years and then
yearly. In case of suspicious CXR, further investigation
included conventional or computerised tomography and
pleural effusion cytology. Metastases in other sites were
excluded by physical examination and X-ray or scintigraphic
bone survey.
Treatment was started in all cases of ITM at the time of
first diagnosis. It was not strictly homogeneous in the study
period although hormone therapy (additive in post-
menopause and oophorectomy in premenopause) followed
by chemotherapy in refractory patients was the usual treat-
ment and was completely independent from ITM symptom-
atic or asymptomatic status.
Data were drawn retrospectively from clinical records, the
investigator being blinded when reviewing the survival out-
come. Data available for all ITM cases were patient age, N
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pathologic category (N- =not involved, N+ =involved), the
date of primary treatment and of ITM detection, the
presence of subjective symptoms (A=asymptomatic.
S=symptomatic) related to ITM (cough, dyspnoea, thoracic
pain) and worth further investigation, and final status.
Asymptomatic cases were actually 'screen detected' being
diagnosed on CXR at planned follow-up visits whereas
symptomatic cases were 'interval' cases being diagnosed on
CXR at self-referral because of subjective symptoms in the
interval between two consecutive planned controls. Interval
cases did always refer to the study centre at the time of
recurrence.
The average disease-free interval and overall survival from
primary treatment were evaluated according to the symptom-
atic status at ITM diagnosis. Survival curves were deter-
mined (Kaplan & Meyer, 1958) and the statistical difference
between curves was calculated by the log rank test (Peto &
Peto, 1972).
A multivariate analysis of the correlations between prog-
nosis and symptomatic status at ITM detection was carried
out according to Cox's logistic regression model (Cox, 1972)
in order to adjust simultaneously for potential confounders.
Death from disease was the considered event whereas the
categorical variables entering the final model were patient
age, nodal status and symptomatic status at ITM diagnosis.
Patient status was assessed in October 1987, one case being
lost to follow-up.
Results
Subjective symptoms at diagnosis were present in 80 and
absent in 102 cases respectively. Nodal status was negative,
positive or unknown in 43, 53 or six asymptomatic and in
20, 57 or three symptomatic cases respectively. No signifi-
cant age difference was recorded, the average age being 54.5
or 52.0 in A or S cases respectively (P=0.2). The mean
disease-free interval was shorter for A (28.54 months, s.d.
21.38) with respect to S cases (40.31 months, s.d. 25.50,
P<0.001).
Figure I shows the survival curves from primary treatment
for A or S cases. Overall survival rates at 3, 5 and 10 years
were 0.71, 0.46 and 0.12 for A or 0.70, 0.47 and 0.10 for S
cases with no statistical difference (P=0.68). Patients alive at
10 years were six or four in A or S cases series respectively.
Table I shows the results of multivariate analysis. Nodal
status was weakly related to survival although it did not
reach statistical significance (P=0.055), whereas age and
symptomatic status showed no significant correlation.
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Fgwe 1 Overall survival curves (Kaplan-Meier) of ITM cases
according to the absence ( ) or presence (---) of subjective
symptoms at diagnosis.
On the basis of the reported results, periodic CXR survey
actually allows for early detection of ITM: 56% of total
ITM observed were detected as subjectively asymptomatic
and the average diagnostic anticipation with respect to
symptomatic cases was about 12 months. Unfortunately such
an early detection had no evident impact on prognosis, as
survival was independent from ITM symptomatic status at
diagnosis.
Survival was calculated since primary treatment rather
than since ITM detection to avoid the lead time bias due to
early detection of A cases. On the contrary, length-biased
Table I Multivanate analysis of the relative risk of death from
breast cancer (RR) according to age (continuous variable), patho-
logical nodal status (N-, N+) or asymptomatic/symptomatic (A,S)
status at ITM diagoss
RR 95% CI 2 p
Age - - 0.06 0.81
Nodal status
N- 1.00 - - -
N+ 1.39 0.99-1.95 3.67 0.055
Symptoms
A 1.00 - - -
S 0.85 0.61-1.18 0.93 0.33
95% confidence interval (95% CI), X2 and P value are indicated.
RR is assumed to be I for reference categorical variables (N-,A).
sampling cannot be excluded. In fact, slow growing metas-
tases are more likely to be detected as asymptomatic as they
stay for a longer period in the phase of preclinical detect-
ability. The same bias might account for the selection in the
asymptomatic group of indolent cancers which are more
likely to present a smaler volume of the disease at diagnosis
and a higher probability of hormone sensitivity. Thus,
because of length-biased sampling, a more favourable prog-
nosis of A cases might be more or less totally ascribed to a
selection of slow growing ITM more likely to respond to
treatment. Actually, no survival difference was observed in
this study. Length bias sampling probably occurred but this
does not affect the implications of the final finding that early
detection in the asymptomatic phase has no favourable
prognostic impact. No therapeutic selection bias was
detected as treatment was never delayed until symptoms
onset in patients with asymptomatic ITM and the type of
treatment was absolutely independent from symptomatic
status.
In conclusion, according to the present experience periodic
CXR survey of breast cancer patients allowed for early
detection of ITM but it did not improve life expectancy.
CXR survey seems to us a very questionable policy and its
routine use should be carefully reconsidered.
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